ImmunoSite Technologies Allies with Goodwin Biotechnology Increasing Capabilities // Julie Wilkinson

Working together, companies offer enhanced abilities to develop, test and manufacture biopharmaceuticals

Full release click here

Fort Lauderdale, Fla. – November 1, 2011 – ImmunoSite Technologies (IST), LLC, a leading provider of immune monitoring services, has entered into a strategic agreement with Goodwin Biotechnology, Inc. (GBI), a full service Contract Manufacturing Organization focused on process development and GMP manufacturing of cell culture derived biopharmaceuticals, based in Plantation, Fla.

READ MORE

ImmunoSite Technologies Aides in Curriculum Development for Employ Florida Banner Center // Julie Wilkinson

Cell Culture Course helps Floridians enter, remain and advance in the workforce

Full release click here.

Fort Lauderdale, Fla. – October 18, 2011 – ImmunoSite Technologies (IST), LLC, a leading provider of immune monitoring services, has helped develop a Cell Culture Workshop that will be offered for the first time October 27 and 28 at the Employ Florida Banner Center for Life Sciences, based at Palm Beach State College’s Eissey Campus in Palm Beach Gardens.

READ MORE

ImmunoSite Technologies Allies with Immudex for More Effective T Cell Response Monitoring // Julie Wilkinson

Fort Lauderdale, FL. – ImmunoSite Technologies (IST), LLC, a leading provider of immune monitoring services, has entered into a strategic agreement with Immudex, the sole proprietor of MHC Dextramer^TM technology.

Dextramers are superior reagents for the detection of antigen-specific T cells, having the ability to interact simultaneously with multiple receptors on a single T cell with unsurpassed avidity. The increased avidity of Dextramers compared to conventional MHC multimer reagents enhances resolution and signal-to-noise ratio providing a more accurate assessment of the T cell response, and clearly identifying responses previous generation technologies might miss.

READ MORE

ImmunoSite Technologies Provides Particle Testing Services to Beckman Coulter Customers // Admin

Leading provider of particle testing services now receives referrals of customers seeking particle characterization services from Beckman Coulter, Inc.

Fort Lauderdale, Fla. – April 3, 2011 – ImmunoSite Technologies, LLC, a leading provider of immune monitoring services, is now receiving direct customer referrals for particle testing services from Beckman Coulter, Inc. as part of a recent collaboration agreement. READ MORE

ImmunoSite Technologies develops quality assurance materials // Admin

ImmunoSite Technologies Has Been Working With The “CD4 Initiative” To Develop Quality Assurance Materials For Novel, Disposable, CD4 Point-Of-Care Test For Developing Nations

The CD4 Initiative at Imperial College, London, funded by Bill and Melinda Gates Foundation grants, is nearing a major breakthrough in HIV/AIDS care by developing a simple, inexpensive CD4 point-of-care test specifically designed for resource-poor settings.  ImmunoSite Technologies has been developing QA materials for the innovative, disposable test kit. READ MORE